Plus   Neg

Stock Alert: Scientific Games Trading Up 5%

Shares of Scientific Games Corporation (SGMS) are climbing more than 5% Friday morning at $16. It has been trading in the range of $3.76- $31.63 in the last 52 weeks.

Thursday, while reporting second-quarter results, the company's President and Chief Executive Officer, Barry Cottle said, Scientific Games could deliver better-than-expected cash flow for the quarter by strong cost containment and cash management during the Covid-19 pandemic.

Second-quarter revenue decreased to $539 million from was $845 million in the prior-year quarter, negatively impacted by temporary closure of casino operations due to Covid-19.

The company reported net loss of $203 million or $2.15 per share wider than net loss of $77 million or $0.83 last year.

For comments and feedback contact: editorial@rttnews.com

Business News

Get Access to Premium Stock Alerts with RTT Intelligent Investor.
Editors Pick
The U.S. Food and Drug Administration granted emergency use authorization (EUA) for the first and only clinical T cell-based test for patients to detect the unique T-cell signature specific to SARS-CoV-2, the virus that causes COVID-19. The test confirms recent or prior COVID-19 infection. Developed by Adaptive Biotechnologies, T-Detect COVID Test is a next generation sequencing based (NGS) test. AstraZeneca's one batch of Covid vaccine has been suspended by Austrian health authorities following reports of a death and an illness after receiving vaccination, reports said. The issues were reported in the district clinic of Zwettl in Lower Austria province. The Federal Office for Safety in Health Care in the country said the remaining stocks of the affected AstraZeneca/Oxford Covid-19 vaccine DuPont (DD) announced Monday that it has agreed to acquire Laird Performance Materials from with private equity firm Advent International for $2.3 billion. The company will use existing cash balances for the acquisition. The transaction is expected to close in the third quarter of 2021, subject to regulatory...
Follow RTT